Status:
UNKNOWN
Screening of Obstructive Sleep Apnea Syndrome in Patients With Resistant Systemic Arterial Hypertension: Pilot Study
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Sleep Apnea, Obstructive
Resistant Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates the utility and reliability of Somnocheck micro Weinmann for obstructive sleep apnea syndrome (OSAS) screening in patients affected by resistant systemic arterial hypertension. Re...
Detailed Description
OSAS is a syndrome characterized by the partial or total collapse of the high airways which determines snore, airflow limitation, hypopnea and apnea.These events cause desaturations, daytime sleepines...
Eligibility Criteria
Inclusion
- Resistant Arterial Hypertension
- Patients must sign the informed consent
Exclusion
- ,
- atrial fibrillation with haemodynamic instability
- congestive hearth failure,
- BMI\>45 kg/m2,
- respiratory failure
- renal or liver failure,
- stroke,
- implantable cardioverter-defibrillator (ICD),
- pacemaker (PM),
- previous diagnosis of OSAS,
- pregnancy,
- breastfeeding,
- patients must not be already enrolled in other clinical trial.
Key Trial Info
Start Date :
April 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03257488
Start Date
April 1 2015
End Date
February 1 2019
Last Update
August 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda ospedaliera policlinico Sant'Orsola-Malpighi
Bologna, Italy, 40138